Past Event

Corporate Innovation

Why Is It So Hard to Stay One Step Ahead, and What Can Be Done About It?

November 10, 2022
10:00 AM - 11:30 AM EDT (UTC-4)
Corporate Innovation
Leading Edge

Location

Zoom Webinar

 

 


Overview

Corporate innovation—the intentional fostering of out-of-the-box thinking within corporate environments—is essential for large companies to survive, grow, and attract top talent. Still, since 2000, 52% of Fortune 500 companies have "gone bankrupt, been acquired, or ceased to exist" as a result of digital disruption, and 75% of S&P companies will be replaced by 2027, according to Harvard Business Review.

So, why is it so hard for firms to stay one step ahead in a time of disruptive innovation?

Join us as MIT faculty members and research scientists explore the factors that keep firms from problem-solving, leading, and managing innovation in their own organizations—and what they can do about it.

  • Overview

    Corporate innovation—the intentional fostering of out-of-the-box thinking within corporate environments—is essential for large companies to survive, grow, and attract top talent. Still, since 2000, 52% of Fortune 500 companies have "gone bankrupt, been acquired, or ceased to exist" as a result of digital disruption, and 75% of S&P companies will be replaced by 2027, according to Harvard Business Review.

    So, why is it so hard for firms to stay one step ahead in a time of disruptive innovation?

    Join us as MIT faculty members and research scientists explore the factors that keep firms from problem-solving, leading, and managing innovation in their own organizations—and what they can do about it.


Agenda

10:00 AM

Welcome & Introduction
Program Director, MIT Corporate Relations, MIT Corporate Relations
Randall Wright
Randall Wright
Program Director, MIT Corporate Relations

Randall S. Wright is a program director with MIT's Industrial Liaison Program. He manages the interface between the managements of companies, headquartered in the United States and Europe, and the senior administration and faculty of MIT.

As a program director for MIT, he convenes teams of researchers and faculty members to provide on-going emerging technology intelligence and strategic advice for the world's leading technology companies. He is a sought-after speaker, delivering keynote speeches focused on emerging technology opportunities and challenges, and counter-intuitive insights in executive panels and discussions. Randall draws on extensive experience advising executives on a range of emerging technology areas including digital transformation, big data, robotics, green buildings, water efficiency, energy storage, biofuels, advanced materials, and manufacturing. He provides navigation and recommendations on the emerging technologies and adoption landscapes critical to future business growth, as well as creation, development, and execution of programs of research between industry and MIT.

Randall has been bestowed by Federal President of Austria Dr. Heinz Fischer with the decoration Cross of Honor in Gold for Services to the Republic of Austria for his "outstanding contribution to the development of relations between Austria and MIT".

Prior to MIT, Randall was a marketing manager for Pfizer, Inc., a major U.S. pharmaceuticals company. He was also a strategic planning analyst for Pennzoil Company--a Fortune 500 oil and natural resources company. Randall is an invited lecturer at Northeastern University's Executive M.B.A. Program where he lectures on innovation and corporate strategy. His column Innovation Counterculture looks at ideas and perspectives on strategy, organization, and thinking to help executives connect to the world of innovation outside their organizations and he is published regularly in Research-Technology Management, the award-winning journal of the Industrial Research Institute.

10:05 AM
Senior Lecturer, Technological Innovation, Entrepreneurship, and Strategic Management, MIT Sloan School of Management
Phil Budden
Senior Lecturer, Technological Innovation, Entrepreneurship, and Strategic Management

Dr Phil Budden is a Senior Lecturer at MIT's Management School, in Sloan's TIES (Tech Innovation, Entrepreneurship and Strategy) Group, where he focuses on 'corporate innovation’ and multi-stakeholder innovation ecosystems, especially how corporates can get value from the latter (including start-up enterprises).  He works closely with corporate executives and leaders of other large organisations on such strategies, through MIT Corporate Relations/ILP, the Corporate Innovation Program (https://corporateinnovation.mit.edu), Executive Education (https://executive.mit.edu/ci) and MIT’s global REAP program (https://reap.mit.edu), as well as custom and consulting work.

 

 

Innovation is hard, especially for Corporates, and yet it is often key to competitive advantage, i.e., getting and staying one step ahead!  Among the most common challenges is a misreading of what “innovation” is and a misunderstanding of why Startup entrepreneurs seem to be better at it.  As such, ‘corporate innovation’ is hard but strategically important, so we offer practical advice on what can be done about this – i.e., how best to take innovation forwards internally, how to look strategically to the external ecosystem (e.g., university researchers), and how to partner most effectively with Startups and entrepreneurs.

10:20 AM
Merton C. Flemings SMA Professor of Materials Science and Engineering
Eugene A. Fitzgerald
Merton C. Flemings SMA Professor of Materials Science and Engineering

Eugene A. Fitzgerald is the Merton C. Flemings SMA Professor of Materials Engineering at the Massachusetts Institute of Technology. Building upon his early experience at AT&T Bell Labs which included the invention of high mobility strained silicon, he has created fundamental innovations in stages from early technology to final implementation in the market. His research interests include novel thin film materials and devices. He is founder, co-founder or founding team member of AmberWave Systems Corporation, Contour Semiconductor, 4Power LLC (high efficiency III-V solar on silicon), Paradigm Research LLC, and The Water Initiative. He is co-author of “Inside Real Innovation”, published internationally in January of 2011. He is recipient of the IEEE 2011 Andrew S. Grove Award, the IEEE 2004 EDS George Smith Award, and the TMS 1994 Robert Lansing Hardy Medal Award. He received a BS degree in Materials Science and Engineering in 1985 from MIT and his PhD in the same discipline from Cornell University in 1989.

Innovation—the process of putting ideas together into a useful form and bringing them to market—is the true engine of economic growth. And yet, despite the fact, the human process of innovation is the most powerful driver of growth, and humans are the ones doing it, the workings of this process are still not widely understood. Innovation is not a straight-line process as most people believe it to be, but a highly iterative process that typically includes juggling and re-considering many technical and business factors, with an ever-changing view on how the idea might be implemented and the markets that are likely to be interested. Professor Gene Fitzgerald will present an end-to-end process for innovation, based upon time-tested principles, and a vision for corporate innovation that addresses the deficiencies of open innovation.

10:35 AM
Olivier Cadet headshot2
Olivier J Cadet
Program Director

Olivier Cadet is Senior Vice President Global Operations, Americas, and President of Kongsberg Maritime Inc. located in Houston, TX. He is responsible for Kongsberg Maritime operations in the Americas region, with a focus on customer support for the fleet of vessels using Kongsberg Maritime’s technologies. Prior to assuming his role in July 2018, Olivier was Executive Vice President of Products & Services, based in Norway. In that role, Olivier was overseeing the teams managing Kongsberg Maritime’s products portfolio aligned with market demands and future trends, such as autonomous operations and digital performance. Olivier was also accountable for Kongsberg Maritime’s strategic initiative around Information Management System and Smart Data.

Olivier started his international career in the offshore drilling industry in 1998, working for Schlumberger/Transocean as a Controls Engineer where he was involved in the installation, commissioning and support of Dynamic Positioning and Automation systems on offshore drilling rigs. In 2004 Olivier joined Air Liquide, the world leader in industrial gases, where he served for 9 years in a variety of innovation management roles, including R&D Group Manager and Program Director, driving Air Liquide’s research efforts in the field of Advanced Process Control and Operations Research to support the company’s efficiency program.
A dual citizen (U.S./France), Olivier graduated from the Grenoble Institute of Technology (INP Grenoble) in France in 1998 with a Master of Engineering (Diplôme d’Ingénieur) in Electrical Engineering. He completed the Advanced Management Program with MIT Sloan Executive Education in June 2022.

Olivier Cadet, Program Director with MIT Corporate Relations, recently joined MIT after a 24-year international career in industry in a variety of technology management positions in the energy and maritime sectors.  From engineering to R&D and product development, Cadet has contributed to different facets of innovation in market segments that traditionally have a high barrier to entry such as offshore drilling, industrial gases product, and distribution or maritime transportation. Cadet brings executive perspective to three key challenges he sees to corporate innovation: prioritizing projects, working across silos, and engaging with ecosystems.

10:50 AM
Senior Lecturer, System Dynamics
MIT Sloan School of Management
John Carrier
Senior Lecturer, System Dynamics
MIT Sloan School of Management

John Carrier is a Senior Lecturer of System Dynamics at the MIT Sloan School of Management.

Carrier instructs senior managers on improving manufacturing and business processes and serves as an on-site coach in support of projects. His research focuses on strategic marketing and new business development in high technology, specialty chemicals, and service segments. Carrier has more than 15 years of experience in a variety of corporate, entrepreneurial, and consulting environments. Since 2006, he has worked with Arsenal Capital Partners as director of Six Sigma, where he is responsible for increasing portfolio company valuation by adapting and applying Six Sigma techniques to midsize companies. Carrier also handles due diligence, post-merger integrations, and financial analysis and improvement. Prior to joining Arsenal Capital Partners, he was employed by Grace Construction Products; Bain & Company, Inc.; and SuperCool LLC.

Carrier holds a BS in chemical engineering from the University of Michigan, a PhD in chemical engineering from MIT, and an MBA from Harvard Business School.

Do you suspect there is lost capacity in your current system? And are you stymied by the problem that when you ask what can be done, your staff asks for even more resources? You are not alone.

This phenomenon – first identified as hidden factories by MIT Sloan Alum Armand Feigenbaum – is common to all systems and driven by short-term fixes that ultimately result in 20 – 30% loss in human activity.

11:05 AM
Program Director, MIT Startup Exchange
Catarina Madeira
Program Director

Catarina Madeira joined Corporate Relations in May 2021 as Program Director, Startup Exchange.

Madeira has been working with the Cambridge/Boston startup ecosystem for the past 10 years and joins Corporate Relations with a solid network in the innovation and entrepreneurial community. In 2010, she joined the startup accelerator IUL MIT Portugal working in Lisbon and working with the Cambridge team on all aspects related to the accelerator’s launch. She held positions including Operations Coordinator, Program Manager, and Business Developer. The accelerator soon achieved steady growth in large part due to the partnerships that Catarina led with regional and global startup ecosystems. Most recently she worked at NECEC, leading a program that connects cleantech startups and industry. In this role, she developed and built a pipeline of startups and forged strong relationships with both domestic and European companies. She has also held positions in Portugal and France including at L’Oréal and Saboaria e Perfumaria Confiança as Pharmacist and Technical Director.

Madeira earned her Bachelor in Chemistry at the University of Porto and her Bachelor in Pharmaceutical Sciences at the University of Coimbra in Portugal. She went on to earn her Master of Engineering for Health and Medicines at University Lyon 1 and EM Lyon in France.

11:10 AM
Moderator:
Senior Lecturer, Technological Innovation, Entrepreneurship, and Strategic Management, MIT Sloan School of Management
Phil Budden
Senior Lecturer, Technological Innovation, Entrepreneurship, and Strategic Management

Dr Phil Budden is a Senior Lecturer at MIT's Management School, in Sloan's TIES (Tech Innovation, Entrepreneurship and Strategy) Group, where he focuses on 'corporate innovation’ and multi-stakeholder innovation ecosystems, especially how corporates can get value from the latter (including start-up enterprises).  He works closely with corporate executives and leaders of other large organisations on such strategies, through MIT Corporate Relations/ILP, the Corporate Innovation Program (https://corporateinnovation.mit.edu), Executive Education (https://executive.mit.edu/ci) and MIT’s global REAP program (https://reap.mit.edu), as well as custom and consulting work.

 

 

Director, Oral Care Product Development & Scientific Capabilities, Colgate-Palmolive, Co.
Thomas Boyd
Director, Oral Care Product Development & Scientific Capabilities

Thomas Boyd leads a global team of scientists to deliver product solutions across a range of oral health indications, including therapeutic benefit areas such perio, sensitivity, and caries/cavities, as well as cosmetic benefit areas, such as whitening and oral freshness.   He is also responsible for delivering a pipeline of product innovation for the dental profession, both through internal development and external partnerships.  Prior to this role, Dr. Boyd developed and directed the company’s strategic partnerships with universities and expanded capabilities to tap into emerging start-up networks.  Models he designed for effective & productive collaboration have served as a template for other Industry-University partnerships. His strong networks within the global ecosystem of start-ups and entrepreneurs have also brought new breakthrough opportunities into incubation & development.

In addition to his focus on technology innovation, Dr. Boyd has advanced Colgate’s innovation capabilities, including the establishment of the Future of Innovation workshops at MIT, the development of a global network of internal & external technology scouts, as well as championing consumer-focused innovation within R&D.

Dr. Boyd’s passion for consumer-focused innovation has led to more than 85 US patents, numerous publications, and internal and external awards.  He holds a Ph.D. in chemistry from the Massachusetts Institute of Technology (MIT), where he studied under Nobel laureate Professor Emeritus Dr. Richard Schrock.

CEO, LiquiGlide
Dan Rippy
CEO

Dan Rippy, LiquiGlide’s CEO, is an accomplished business executive with more than twenty-five of experience. He has done transactions worth more than $3 billion in deal value and has an extensive background in executive management, corporate development, strategic planning, finance, marketing, company formation, and fundraising. He has experience across consumer, pharmaceutical, medical device, and diagnostic markets.   

Mr. Rippy joined LiquiGlide in 2021. Previously, he headed business development at Lantheus Medical Imaging, where he led significant deal activity in oncology and cardiology. Previously, he led field finance and business development at Siemens Healthcare Diagnostics. He served as President & CEO of Allegro Diagnostics (acquired by Veracyte), a molecular diagnostics company focused on pulmonary diseases, including lung cancer. Mr. Rippy also headed corporate development for DFB Pharmaceuticals, a privately held $350 million pharmaceutical and medical products company with five operating divisions in dermatology, tissue management, surgery, oncology, and contract manufacturing solutions. Mr. Rippy also served as the C.E.O. of Macrocyclics (acquired by Areva Med), a specialty pharmaceutical company focused on radiopharmaceuticals and radiodiagnostics. Earlier in his career, Mr. Rippy worked in business development at Johnson & Johnson and business development, finance, and marketing at Bristol-Myers Squibb. 

Mr. Rippy holds an S.M. in Health Science and Technology from the Harvard-M.I.T Division of Health Science and Technology, an M.B.A. from Columba Business School, and a B.A. in Political Science and Spanish from Macalester College.

11:30 AM

Adjournment
  • Agenda
    10:00 AM

    Welcome & Introduction
    Program Director, MIT Corporate Relations, MIT Corporate Relations
    Randall Wright
    Randall Wright
    Program Director, MIT Corporate Relations

    Randall S. Wright is a program director with MIT's Industrial Liaison Program. He manages the interface between the managements of companies, headquartered in the United States and Europe, and the senior administration and faculty of MIT.

    As a program director for MIT, he convenes teams of researchers and faculty members to provide on-going emerging technology intelligence and strategic advice for the world's leading technology companies. He is a sought-after speaker, delivering keynote speeches focused on emerging technology opportunities and challenges, and counter-intuitive insights in executive panels and discussions. Randall draws on extensive experience advising executives on a range of emerging technology areas including digital transformation, big data, robotics, green buildings, water efficiency, energy storage, biofuels, advanced materials, and manufacturing. He provides navigation and recommendations on the emerging technologies and adoption landscapes critical to future business growth, as well as creation, development, and execution of programs of research between industry and MIT.

    Randall has been bestowed by Federal President of Austria Dr. Heinz Fischer with the decoration Cross of Honor in Gold for Services to the Republic of Austria for his "outstanding contribution to the development of relations between Austria and MIT".

    Prior to MIT, Randall was a marketing manager for Pfizer, Inc., a major U.S. pharmaceuticals company. He was also a strategic planning analyst for Pennzoil Company--a Fortune 500 oil and natural resources company. Randall is an invited lecturer at Northeastern University's Executive M.B.A. Program where he lectures on innovation and corporate strategy. His column Innovation Counterculture looks at ideas and perspectives on strategy, organization, and thinking to help executives connect to the world of innovation outside their organizations and he is published regularly in Research-Technology Management, the award-winning journal of the Industrial Research Institute.

    10:05 AM
    Senior Lecturer, Technological Innovation, Entrepreneurship, and Strategic Management, MIT Sloan School of Management
    Phil Budden
    Senior Lecturer, Technological Innovation, Entrepreneurship, and Strategic Management

    Dr Phil Budden is a Senior Lecturer at MIT's Management School, in Sloan's TIES (Tech Innovation, Entrepreneurship and Strategy) Group, where he focuses on 'corporate innovation’ and multi-stakeholder innovation ecosystems, especially how corporates can get value from the latter (including start-up enterprises).  He works closely with corporate executives and leaders of other large organisations on such strategies, through MIT Corporate Relations/ILP, the Corporate Innovation Program (https://corporateinnovation.mit.edu), Executive Education (https://executive.mit.edu/ci) and MIT’s global REAP program (https://reap.mit.edu), as well as custom and consulting work.

     

     

    Innovation is hard, especially for Corporates, and yet it is often key to competitive advantage, i.e., getting and staying one step ahead!  Among the most common challenges is a misreading of what “innovation” is and a misunderstanding of why Startup entrepreneurs seem to be better at it.  As such, ‘corporate innovation’ is hard but strategically important, so we offer practical advice on what can be done about this – i.e., how best to take innovation forwards internally, how to look strategically to the external ecosystem (e.g., university researchers), and how to partner most effectively with Startups and entrepreneurs.

    10:20 AM
    Merton C. Flemings SMA Professor of Materials Science and Engineering
    Eugene A. Fitzgerald
    Merton C. Flemings SMA Professor of Materials Science and Engineering

    Eugene A. Fitzgerald is the Merton C. Flemings SMA Professor of Materials Engineering at the Massachusetts Institute of Technology. Building upon his early experience at AT&T Bell Labs which included the invention of high mobility strained silicon, he has created fundamental innovations in stages from early technology to final implementation in the market. His research interests include novel thin film materials and devices. He is founder, co-founder or founding team member of AmberWave Systems Corporation, Contour Semiconductor, 4Power LLC (high efficiency III-V solar on silicon), Paradigm Research LLC, and The Water Initiative. He is co-author of “Inside Real Innovation”, published internationally in January of 2011. He is recipient of the IEEE 2011 Andrew S. Grove Award, the IEEE 2004 EDS George Smith Award, and the TMS 1994 Robert Lansing Hardy Medal Award. He received a BS degree in Materials Science and Engineering in 1985 from MIT and his PhD in the same discipline from Cornell University in 1989.

    Innovation—the process of putting ideas together into a useful form and bringing them to market—is the true engine of economic growth. And yet, despite the fact, the human process of innovation is the most powerful driver of growth, and humans are the ones doing it, the workings of this process are still not widely understood. Innovation is not a straight-line process as most people believe it to be, but a highly iterative process that typically includes juggling and re-considering many technical and business factors, with an ever-changing view on how the idea might be implemented and the markets that are likely to be interested. Professor Gene Fitzgerald will present an end-to-end process for innovation, based upon time-tested principles, and a vision for corporate innovation that addresses the deficiencies of open innovation.

    10:35 AM
    Olivier Cadet headshot2
    Olivier J Cadet
    Program Director

    Olivier Cadet is Senior Vice President Global Operations, Americas, and President of Kongsberg Maritime Inc. located in Houston, TX. He is responsible for Kongsberg Maritime operations in the Americas region, with a focus on customer support for the fleet of vessels using Kongsberg Maritime’s technologies. Prior to assuming his role in July 2018, Olivier was Executive Vice President of Products & Services, based in Norway. In that role, Olivier was overseeing the teams managing Kongsberg Maritime’s products portfolio aligned with market demands and future trends, such as autonomous operations and digital performance. Olivier was also accountable for Kongsberg Maritime’s strategic initiative around Information Management System and Smart Data.

    Olivier started his international career in the offshore drilling industry in 1998, working for Schlumberger/Transocean as a Controls Engineer where he was involved in the installation, commissioning and support of Dynamic Positioning and Automation systems on offshore drilling rigs. In 2004 Olivier joined Air Liquide, the world leader in industrial gases, where he served for 9 years in a variety of innovation management roles, including R&D Group Manager and Program Director, driving Air Liquide’s research efforts in the field of Advanced Process Control and Operations Research to support the company’s efficiency program.
    A dual citizen (U.S./France), Olivier graduated from the Grenoble Institute of Technology (INP Grenoble) in France in 1998 with a Master of Engineering (Diplôme d’Ingénieur) in Electrical Engineering. He completed the Advanced Management Program with MIT Sloan Executive Education in June 2022.

    Olivier Cadet, Program Director with MIT Corporate Relations, recently joined MIT after a 24-year international career in industry in a variety of technology management positions in the energy and maritime sectors.  From engineering to R&D and product development, Cadet has contributed to different facets of innovation in market segments that traditionally have a high barrier to entry such as offshore drilling, industrial gases product, and distribution or maritime transportation. Cadet brings executive perspective to three key challenges he sees to corporate innovation: prioritizing projects, working across silos, and engaging with ecosystems.

    10:50 AM
    Senior Lecturer, System Dynamics
    MIT Sloan School of Management
    John Carrier
    Senior Lecturer, System Dynamics
    MIT Sloan School of Management

    John Carrier is a Senior Lecturer of System Dynamics at the MIT Sloan School of Management.

    Carrier instructs senior managers on improving manufacturing and business processes and serves as an on-site coach in support of projects. His research focuses on strategic marketing and new business development in high technology, specialty chemicals, and service segments. Carrier has more than 15 years of experience in a variety of corporate, entrepreneurial, and consulting environments. Since 2006, he has worked with Arsenal Capital Partners as director of Six Sigma, where he is responsible for increasing portfolio company valuation by adapting and applying Six Sigma techniques to midsize companies. Carrier also handles due diligence, post-merger integrations, and financial analysis and improvement. Prior to joining Arsenal Capital Partners, he was employed by Grace Construction Products; Bain & Company, Inc.; and SuperCool LLC.

    Carrier holds a BS in chemical engineering from the University of Michigan, a PhD in chemical engineering from MIT, and an MBA from Harvard Business School.

    Do you suspect there is lost capacity in your current system? And are you stymied by the problem that when you ask what can be done, your staff asks for even more resources? You are not alone.

    This phenomenon – first identified as hidden factories by MIT Sloan Alum Armand Feigenbaum – is common to all systems and driven by short-term fixes that ultimately result in 20 – 30% loss in human activity.

    11:05 AM
    Program Director, MIT Startup Exchange
    Catarina Madeira
    Program Director

    Catarina Madeira joined Corporate Relations in May 2021 as Program Director, Startup Exchange.

    Madeira has been working with the Cambridge/Boston startup ecosystem for the past 10 years and joins Corporate Relations with a solid network in the innovation and entrepreneurial community. In 2010, she joined the startup accelerator IUL MIT Portugal working in Lisbon and working with the Cambridge team on all aspects related to the accelerator’s launch. She held positions including Operations Coordinator, Program Manager, and Business Developer. The accelerator soon achieved steady growth in large part due to the partnerships that Catarina led with regional and global startup ecosystems. Most recently she worked at NECEC, leading a program that connects cleantech startups and industry. In this role, she developed and built a pipeline of startups and forged strong relationships with both domestic and European companies. She has also held positions in Portugal and France including at L’Oréal and Saboaria e Perfumaria Confiança as Pharmacist and Technical Director.

    Madeira earned her Bachelor in Chemistry at the University of Porto and her Bachelor in Pharmaceutical Sciences at the University of Coimbra in Portugal. She went on to earn her Master of Engineering for Health and Medicines at University Lyon 1 and EM Lyon in France.

    11:10 AM
    Moderator:
    Senior Lecturer, Technological Innovation, Entrepreneurship, and Strategic Management, MIT Sloan School of Management
    Phil Budden
    Senior Lecturer, Technological Innovation, Entrepreneurship, and Strategic Management

    Dr Phil Budden is a Senior Lecturer at MIT's Management School, in Sloan's TIES (Tech Innovation, Entrepreneurship and Strategy) Group, where he focuses on 'corporate innovation’ and multi-stakeholder innovation ecosystems, especially how corporates can get value from the latter (including start-up enterprises).  He works closely with corporate executives and leaders of other large organisations on such strategies, through MIT Corporate Relations/ILP, the Corporate Innovation Program (https://corporateinnovation.mit.edu), Executive Education (https://executive.mit.edu/ci) and MIT’s global REAP program (https://reap.mit.edu), as well as custom and consulting work.

     

     

    Director, Oral Care Product Development & Scientific Capabilities, Colgate-Palmolive, Co.
    Thomas Boyd
    Director, Oral Care Product Development & Scientific Capabilities

    Thomas Boyd leads a global team of scientists to deliver product solutions across a range of oral health indications, including therapeutic benefit areas such perio, sensitivity, and caries/cavities, as well as cosmetic benefit areas, such as whitening and oral freshness.   He is also responsible for delivering a pipeline of product innovation for the dental profession, both through internal development and external partnerships.  Prior to this role, Dr. Boyd developed and directed the company’s strategic partnerships with universities and expanded capabilities to tap into emerging start-up networks.  Models he designed for effective & productive collaboration have served as a template for other Industry-University partnerships. His strong networks within the global ecosystem of start-ups and entrepreneurs have also brought new breakthrough opportunities into incubation & development.

    In addition to his focus on technology innovation, Dr. Boyd has advanced Colgate’s innovation capabilities, including the establishment of the Future of Innovation workshops at MIT, the development of a global network of internal & external technology scouts, as well as championing consumer-focused innovation within R&D.

    Dr. Boyd’s passion for consumer-focused innovation has led to more than 85 US patents, numerous publications, and internal and external awards.  He holds a Ph.D. in chemistry from the Massachusetts Institute of Technology (MIT), where he studied under Nobel laureate Professor Emeritus Dr. Richard Schrock.

    CEO, LiquiGlide
    Dan Rippy
    CEO

    Dan Rippy, LiquiGlide’s CEO, is an accomplished business executive with more than twenty-five of experience. He has done transactions worth more than $3 billion in deal value and has an extensive background in executive management, corporate development, strategic planning, finance, marketing, company formation, and fundraising. He has experience across consumer, pharmaceutical, medical device, and diagnostic markets.   

    Mr. Rippy joined LiquiGlide in 2021. Previously, he headed business development at Lantheus Medical Imaging, where he led significant deal activity in oncology and cardiology. Previously, he led field finance and business development at Siemens Healthcare Diagnostics. He served as President & CEO of Allegro Diagnostics (acquired by Veracyte), a molecular diagnostics company focused on pulmonary diseases, including lung cancer. Mr. Rippy also headed corporate development for DFB Pharmaceuticals, a privately held $350 million pharmaceutical and medical products company with five operating divisions in dermatology, tissue management, surgery, oncology, and contract manufacturing solutions. Mr. Rippy also served as the C.E.O. of Macrocyclics (acquired by Areva Med), a specialty pharmaceutical company focused on radiopharmaceuticals and radiodiagnostics. Earlier in his career, Mr. Rippy worked in business development at Johnson & Johnson and business development, finance, and marketing at Bristol-Myers Squibb. 

    Mr. Rippy holds an S.M. in Health Science and Technology from the Harvard-M.I.T Division of Health Science and Technology, an M.B.A. from Columba Business School, and a B.A. in Political Science and Spanish from Macalester College.

    11:30 AM

    Adjournment